Skip to main content
Menu Directory Menu
Calendar
Member Directory
User account menu
Cart
Log in
IP FOR BUSINESS
Fulltext search
Submit
JOIN FICPI
Join Ficpi
Main navigation
Home
About
What Does FICPI Do?
The FICPI Global Community
How FICPI Advances the Interests of its Members
FICPI’s Achievements
The Inclusion Project
Strategic Plan
Governance
Organisation
National Associations
National and Regional Sections
Global Individual Members
Executive Committee (EXCO)
The Bureau
Permanent Secretariat
Advisory Council
Committees
Study & Work (CET)
CET - Executive
CET 1 - Trade Marks
CET 2 - Designs
CET 3 - International Patent Matters
CET 4 - European Patents
CET 5 - Biotechnology & Pharmaceuticals
CET 6 - Software, High-tech & Computer Related Issues
CET 7 - IP Enforcement & Alternate Dispute Resolution
Practice Management (PMC)
The FICPI Academy
Diversity, Equity, Inclusivity & Accessibility (DEIA)
Webinar Committee
OTHER COMMITTEES
Admission (ADM)
Deontology (DEO)
Communications (COM)
European Members (EUCOF)
Finance Advisory Board (FAB)
Membership (MEM)
Nominating (NOM)
Statutes (STAT)
Strategic Planning (SPC)
Past Presidents, Distinctions & Awards
Past Presidents & Bureaux Members
Presidents of Honour
Members of Honour
The Malcolm Royal Award
Emeritus Members
Find a FICPI Member
EVENTS/TRAINING
Upcoming Conferences & Events
Past FICPI Meetings
About FICPI Conferences & Events
About FICPI Events
First-time Attendees
Sponsors & Exhibitors
FICPI Training Courses
2024 SEAD Patent Drafting Course
Venue, Fees & Entry Requirements
Webinars
Upcoming Webinars
About FICPI Webinars
The Connect, Share & Grow Series
The Webinar Committee
Calendar of Events
Library
FICPI Resolutions
Conference Presentations
IP Practice Management
FICPI Viewpoints
Colloquium Papers
FICPI On-Demand
FICPI Brochures
Document Search
News
FICPI News
IP News
Industry News
Blog
Contact
Menu Directory Menu
Calendar
Member Directory
Pharma patent
The main obstacles to obtain patent protection for CAR-T cell-related technologies in Brazil
Posted by
Luis Maciel, Kene Gallois, Samantha Salim
15 Nov 2023
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
,
IP news and developments
As research and development efforts move forward in relation to Chimeric antigen receptor CAR-T cells, it is...
READ MORE
Patent protection for CRISPR/cas-9 technologies in Brazil
Posted by
Kene Gallois, Isabel Moraes, Rana Gosain
13 Nov 2023
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
Genome editing using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 9 (Cas-9) technology holds great potential...
READ MORE
Insights for patent protection of CAR-T cells-related technologies in Brazil
Posted by
Luis Maciel, Kene Gallois, Samantha Salim
21 Sep 2023
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
,
IP news and developments
Chimeric antigen receptor (CAR) T-cell therapy is a personalised cancer treatment that is gaining greater visibility...
READ MORE
Patenting of stem cells
Posted by
Serge Shahinian
01 Aug 2023
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
What are stem cells and why are they so important? The body is an amazing thing, made...
READ MORE
Maximising Patent Term Extension in Korea: strategies and recommendations
Posted by
Min Son
24 Jul 2023
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
Patent Term Extension (PTE) in Korea provides an opportunity to extend the term of a patent...
READ MORE
Australia’s Full Federal Court diagnoses an outcome, not a product
Posted by
Andrew Scott
05 May 2022
0
IP laws and practice (includes legislation, practice changes, case-law from around the world)
Examining a recent court decision; the latest in a long running, multi-jurisdictional dispute between the parties...
READ MORE
Patent exceptions during a pandemic
Posted by
Jean Akl
28 Jul 2020
0
IP asset management (valuation, licensing, FRAND etc.)
The thorny issue of compulsory licensing....
READ MORE
BECOME A MEMBER OF FICPI
FICPI is the only international NGO whose membership consists exclusively of IP attorneys in private practice. As a result, the FICPI community is driven by a shared interest to promote solutions and advocacy for private IP practitioners.
BECOME A MEMBER OF FICPI
MEMBER LOGIN